Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 10 | 0 | €68.00 | €72.96 | 7.289% |
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | €126.15 | €140.34 | 11.249% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €301.60 | €335.03 | 11.084% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €62.00 | €79.55 | 28.313% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €209.70 | €294.01 | 40.205% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €398.60 | €408.36 | 2.448% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €285.95 | €297.31 | 3.973% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.61 | €86.77 | 38.590% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €16.06 | €28.06 | 74.770% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €701.20 | €760.00 | 8.386% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €155.32 | €200.06 | 28.803% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €74.00 | €86.90 | 17.428% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 4 | 0 | €905.80 | €957.22 | 5.677% |
| Align Technology | 15 | 2 | 4 | 0 | €252.70 | €345.95 | 36.901% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.53 | €35.43 | 38.775% |